ANAVEX LIFE SCIENCES CORP. Payments of Financing Costs
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Payments of Financing Costs of $706.80 thousand for the 9-month period ending 2022-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2023-08-08
- ANAVEX LIFE SCIENCES CORP. payments of financing costs for the quarter ending 2022-06-30 was $185.36K, a 95.79% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. payments of financing costs for the quarter ending 2022-03-31 was $374.72K, a 56.99% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. payments of financing costs for the quarter ending 2021-12-31 was $146.72K, a 44.31% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. payments of financing costs for the quarter ending 2021-06-30 was $4.40M, a 17848.28% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. payments of financing costs for fiscal 2014 was $788.71K.
- ANAVEX LIFE SCIENCES CORP. payments of financing costs for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- ANAVEX LIFE SCIENCES CORP. payments of financing costs for fiscal 2012 was $8.15K.
- ANAVEX LIFE SCIENCES CORP. payments of financing costs for fiscal 2011 was $0.00.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 9 month as first filed | Payments of Financing Costs 12 month | Payments of Financing Costs 12 month as first filed | Payments of Financing Costs 92 month | Payments of Financing Costs 95 month | Payments of Financing Costs 98 month | Payments of Financing Costs 101 month | Payments of Financing Costs 104 month | Payments of Financing Costs 107 month | Payments of Financing Costs 110 month | Payments of Financing Costs 113 month | Payments of Financing Costs 116 month | Payments of Financing Costs 119 month | Payments of Financing Costs 122 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-30 | $185.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | $560.09K derived: sum of 2 quarters · filed 2023-08-08 | $706.80K 10-Q · filed 2023-08-08 | ||||||||||||||
| 2022-03-31 | $374.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-09 | $521.44K 10-Q · filed 2023-05-09 | |||||||||||||||
| 2021-12-31 | $146.72K 10-Q · filed 2023-02-07 | ||||||||||||||||
| 2021-06-30 | $4.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-09 | $5.27M derived: sum of 2 quarters · filed 2022-08-09 | $5.53M 10-Q · filed 2022-08-09 | $5.53M 10-Q · filed 2021-08-12 | |||||||||||||
| 2021-03-31 | $871.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-10 | $1.13M 10-Q · filed 2022-05-10 | |||||||||||||||
| 2020-12-31 | $263.46K 10-Q · filed 2022-02-09 | ||||||||||||||||
| 2020-06-30 | $24.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | $24.51K derived: sum of 2 quarters · filed 2021-08-12 | $24.51K 10-Q · filed 2021-08-12 | ||||||||||||||
| 2020-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-13 | $0.00 10-Q · filed 2021-05-13 | |||||||||||||||
| 2019-12-31 | $0.00 10-Q · filed 2021-02-16 | ||||||||||||||||
| 2015-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-14 | $0.00 10-Q · filed 2015-08-14 | |||||||||||||||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-14 | ||||||||||||||||
| 2014-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | $53.87K derived: sum of 2 quarters · filed 2016-12-14 | $788.71K derived: sum of 3 quarters · filed 2016-12-14 | $788.71K 10-K · filed 2016-12-14 | |||||||||||||
| 2014-06-30 | $53.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-14 | $788.71K derived: sum of 2 quarters · filed 2015-08-14 | $788.71K 10-Q · filed 2015-08-14 | $788.71K derived: sum of 4 quarters · filed 2015-08-14 | |||||||||||||
| 2014-03-31 | $734.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-14 | $734.84K 10-Q · filed 2015-05-14 | $734.84K derived: sum of 3 quarters · filed 2015-05-14 | $734.84K derived: sum of 4 quarters · filed 2015-05-14 | $842.99K 10-Q/A · filed 2014-05-30 | ||||||||||||
| 2013-12-31 | $0.00 10-Q · filed 2014-02-14 | $0.00 derived: sum of 2 quarters · filed 2014-12-29 | $0.00 derived: sum of 3 quarters · filed 2014-12-29 | $0.00 derived: sum of 4 quarters · filed 2014-12-29 | $108.15K 10-Q · filed 2014-02-14 | ||||||||||||
| 2013-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29 | $0.00 derived: sum of 2 quarters · filed 2014-12-29 | $0.00 derived: sum of 3 quarters · filed 2014-12-29 | $0.00 10-K · filed 2014-12-29 | $108.15K 10-K · filed 2013-12-30 | ||||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2014-08-13 | $0.00 derived: sum of 2 quarters · filed 2014-08-13 | $0.00 10-Q · filed 2014-08-13 | $4.90K derived: sum of 4 quarters · filed 2014-08-13 | $108.15K 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2014-05-30 | $0.00 10-Q/A · filed 2014-05-30 | $4.90K derived: sum of 3 quarters · filed 2014-05-30 | $8.15K derived: sum of 4 quarters · filed 2014-05-30 | $108.15K 10-Q · filed 2013-05-17 | ||||||||||||
| 2012-12-31 | $0.00 10-Q · filed 2014-02-14 | $4.90K derived: sum of 2 quarters · filed 2014-02-14 | $8.15K derived: sum of 3 quarters · filed 2014-02-14 | $8.15K derived: sum of 4 quarters · filed 2014-02-14 | $108.15K 10-Q · filed 2013-02-14 | ||||||||||||
| 2012-09-30 | $4.90K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | $8.15K derived: sum of 2 quarters · filed 2013-12-30 | $8.15K derived: sum of 3 quarters · filed 2013-12-30 | $8.15K 10-K · filed 2013-12-30 | $108.15K 10-K · filed 2012-12-31 | ||||||||||||
| 2012-06-30 | $3.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-14 | $3.25K derived: sum of 2 quarters · filed 2013-08-14 | $3.25K 10-Q · filed 2013-08-14 | $3.25K derived: sum of 4 quarters · filed 2013-08-14 | $103.25K 10-Q · filed 2012-08-17 | ||||||||||||
| 2012-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-17 | $0.00 10-Q · filed 2013-05-17 | $0.00 derived: sum of 3 quarters · filed 2013-05-17 | $0.00 derived: sum of 4 quarters · filed 2013-05-17 | $100.00K 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | $0.00 10-Q · filed 2013-02-14 | $0.00 derived: sum of 2 quarters · filed 2013-02-14 | $0.00 derived: sum of 3 quarters · filed 2013-02-14 | $0.00 derived: sum of 4 quarters · filed 2013-02-14 | $100.00K 10-Q · filed 2012-02-14 | ||||||||||||
| 2011-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-31 | $0.00 derived: sum of 2 quarters · filed 2012-12-31 | $0.00 derived: sum of 3 quarters · filed 2012-12-31 | $0.00 10-K · filed 2012-12-31 | $100.00K 10-K · filed 2011-12-22 | $100.00K 10-K · filed 2011-12-22 | |||||||||||
| 2011-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-17 | $0.00 derived: sum of 2 quarters · filed 2012-08-17 | $0.00 10-Q · filed 2012-08-17 | ||||||||||||||
| 2011-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15 | $0.00 10-Q · filed 2012-05-15 | |||||||||||||||
| 2010-12-31 | $0.00 10-Q · filed 2012-02-14 | ||||||||||||||||
| 2010-09-30 | $0.00 10-K · filed 2011-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |